Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 7, 2021JAMA OncologyOpen Access

Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant

View Full Paper
Ask AI
Bookmark
Share

Authors

MSMichael ScordoMemorial Sloan Kettering Cancer CenterTWTrent WangUniversity of MiamiKAKwang Woo AhnMedical College of Wisconsin

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Scordo et al. (2021) studied this question.

synapsesocial.com/papers/6a7b62701ba4614d7ff4331ehttps://doi.org/10.1001/jamaoncol.2021.1074
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning2016 · 29 citations
  2. 2Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study2019 · 285 citations
  3. 3The role of whole brain radiation in primary CNS lymphoma2016 · 37 citations
  4. 4Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell Transplantation2015 · 160 citations
  5. 5R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma2015 · 350 citations